LaNova Medicines Funding: $42M Raised, Series C (2024)
LaNova Medicines is based in Shanghai, China. It has raised $42M in total funding. Latest round: Series C.
LaNova Medicines funding overview
LaNova Medicines is based in Shanghai, China. LaNova Medicines has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in October 2024. The round record for LaNova Medicines runs through 2024; nothing later has been disclosed. Investors on record include Sino Biopharmaceuticals Limited, Pudong Innovation Investment, Zhangjiang Haoheng, Qiming Venture Partners, Shanghai Healthcare Capital. 5 distinct backers are named across the disclosed rounds.
LaNova Medicines at a glance
Total raised
$42M
Latest round
Series C
Latest round date
October 2024
Headquarters
Shanghai, China
Notable investors
Sino Biopharmaceuticals Limited, Pudong Innovation Investment, Zhangjiang Haoheng, Qiming Venture Partners, Shanghai Healthcare Capital
Frequently asked about LaNova Medicines funding
How much has LaNova Medicines raised?
LaNova Medicines has raised $42M in total disclosed funding across the rounds on record.
Who has invested in LaNova Medicines?
Sino Biopharmaceuticals Limited, Pudong Innovation Investment, Zhangjiang Haoheng, Qiming Venture Partners, Shanghai Healthcare Capital are named among the investors backing LaNova Medicines.
What was the latest LaNova Medicines funding round?
The most recent disclosed round is a Series C, announced in October 2024.
Where is LaNova Medicines based?
LaNova Medicines is based in Shanghai, China.
When did LaNova Medicines last raise?
The last disclosed LaNova Medicines round closed in October 2024 at Series C.
Totals shown for LaNova Medicines aggregate every disclosed round on file. To see how that compares, browse the companies in Shanghai and the investors behind them below.
